Atlas Trials

Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT03344367 · UNKNOWN

Trial details

NCT number
NCT03344367
Sponsor
Peking University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non Hodgkin Lymphoma
Start date
2017-11-16
Primary completion
2019-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.